retifanlimab-dlwr
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for retifanlimab-dlwr, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1 [Phase 1, Phase 2]